- Home
- ELF vs JAZZ Comparison
ELF vs JAZZ Comparison
Compare ELF & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELF
- JAZZ
- Stock Information
- Founded
- ELF 2004
- JAZZ 2003
- Country
- ELF United States
- JAZZ Ireland
- Employees
- ELF N/A
- JAZZ N/A
- Industry
- ELF Package Goods/Cosmetics
- JAZZ Biotechnology: Pharmaceutical Preparations
- Sector
- ELF Consumer Discretionary
- JAZZ Health Care
- Exchange
- ELF Nasdaq
- JAZZ Nasdaq
- Market Cap
- ELF 6.5B
- JAZZ 6.5B
- IPO Year
- ELF 2016
- JAZZ 2007
- Fundamental
- Price
- ELF $123.84
- JAZZ $121.47
- Analyst Decision
- ELF Strong Buy
- JAZZ Buy
- Analyst Count
- ELF 14
- JAZZ 14
- Target Price
- ELF $168.07
- JAZZ $173.57
- AVG Volume (30 Days)
- ELF 2.9M
- JAZZ 613.8K
- Earning Date
- ELF 11-06-2024
- JAZZ 11-06-2024
- Dividend Yield
- ELF N/A
- JAZZ N/A
- EPS Growth
- ELF N/A
- JAZZ 458.10
- EPS
- ELF 1.86
- JAZZ 7.04
- Revenue
- ELF $1,217,638,000.00
- JAZZ $3,992,712,000.00
- Revenue This Year
- ELF $31.16
- JAZZ $7.43
- Revenue Next Year
- ELF $16.38
- JAZZ $6.39
- P/E Ratio
- ELF $66.28
- JAZZ $17.64
- Revenue Growth
- ELF 59.01
- JAZZ 5.23
- 52 Week Low
- ELF $98.50
- JAZZ $99.06
- 52 Week High
- ELF $221.83
- JAZZ $134.17
- Technical
- Relative Strength Index (RSI)
- ELF 58.05
- JAZZ 59.35
- Support Level
- ELF $120.88
- JAZZ $108.74
- Resistance Level
- ELF $134.56
- JAZZ $128.99
- Average True Range (ATR)
- ELF 6.61
- JAZZ 2.93
- MACD
- ELF 2.21
- JAZZ 1.13
- Stochastic Oscillator
- ELF 70.28
- JAZZ 62.86
About ELF e.l.f. Beauty Inc.
e.l.f. Beauty Inc is a multi-brand beauty company that offers inclusive, accessible, clean, vegan and cruelty-free cosmetics and skin care products. The Company's mission is to make the best of beauty accessible to every eye, lip, face, and skin concern. The company offers cosmetic accessories for women which include eyeliner, mascara, false eyelashes, lipstick, the foundation for the face, moisturizer, cleanser, and other tools through its stores and e-commerce channels. The products that the company sells are marketed under the e.l.f. Cosmetics, W3LL PEOPLE and Keys Soulcare brands. It carries out sales within the US and internationally, out of which maximum revenue is generated from the US.
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.